Invention Grant
- Patent Title: Pharmaceutical composition for ANO1 antagonist with anticancer activity
-
Application No.: US16574701Application Date: 2019-09-18
-
Publication No.: US11274074B2Publication Date: 2022-03-15
- Inventor: Wan Namkung , Ik Yon Kim , Yohan Seo , Jin Hwang Kim
- Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
- Applicant Address: KR Seoul
- Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
- Current Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
- Current Assignee Address: KR Seoul
- Agency: Duane Morris LLP
- Agent Gregory M. Lefkowitz
- Priority: KR10-2018-0112056 20180919
- Main IPC: C07C251/80
- IPC: C07C251/80 ; A61P35/00 ; C07C243/18 ; C07D271/06 ; C07D307/54 ; C07D413/04 ; C07D213/56 ; C07D263/58 ; C07D277/54 ; A61K9/20 ; A61K9/48 ; A61K9/00 ; C07C233/29
Abstract:
The present disclosure relates to a novel anticancer pharmaceutical composition. The present disclosure achieves an anticancer effect using a compound effective in inhibiting the expression of ANO1 (TMEM16A). In addition, the present disclosure provides an ANO1 (TMEM16A) antagonist using the compound inhibiting the expression of ANO1 (TMEM16A).
Public/Granted literature
- US20200087250A1 PHARMACEUTICAL COMPOSITION FOR ANO1 ANTAGONIST WITH ANTICANCER ACTIVITY Public/Granted day:2020-03-19
Information query
